Quickly
Socially
Trending
Crypto
A government committee in the UK advising on coronavirus vaccinations has said people under the age of 30 should be offered an alternative to AstraZeneca vaccine, after 19 people died in the country from rare blood clots after receiving the jab. Altogether, 79 such cases have been reported in the country. AstraZeneca vaccine is being manufactured by the Pune-based Serum Institute under the name of "Covishield". It is one of the two vaccines approved by India's drug regulator in January this year. Oxford University, which developed the vaccine in collaboration with the pharma major, has said they are looking into the connection between the vaccine &the fatal condition, which was earlier reported in other European nations. Initially UK had dissociated the vaccine from the blood clot disorder, but changed its stance as increasing cases were reported. In March, as authorities in Ireland, Denmark, Norway, Iceland, Austria & the Netherlands suspended the use of the AstraZeneca vaccine, the centre said India will continue to use Covishield.
Google Trends
